We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 213

Disease: Pneumococcus

Page 7 of 11
Pneumococcal AMC

This section on the GAVI Alliance's website provides information about the pilot pneumococcal Advance Market Commitment (AMC), which is an innovative funding mechanism. It incentivizes vaccine makers to produce suitable and affordable vaccines for …

Author: GAVI Alliance

Pneumococcal Capsular Polysaccharides Conjugated to Protein D for Prevention of Acute Otitis Media Caused by Both Streptococcus pneumoniae and Non-typable Haemophilus influenzae: A Randomised Double-Blind Efficacy Study

Published in The Lancet, this study assessed the efficacy of a novel vaccine that contained polysaccharides from 11 different Streptococcus pneumoniae serotypes each conjugated to Haemophilus influenzae-derived protein D in prevention of acute …

Author: Prymula R, Peeters P, Chrobok V, et al.

Publication date: 2006

Pneumococcal Conjugate Vaccine for Childhood Immunization - WHO Position Paper

This article, published in Weekly Epidemiological Record, is a summary of pneumococcal disease and its burden, as well as the official World Health Organization (WHO) position on use of conjugate vaccines in a global context. In 2012, the WHO …

Author: World Health Organization

Publication date: 2007

Pneumococcal Conjugate Vaccine (Prevnar; PNCRM7): A Review of Its Use in the Prevention of Streptococcus Pneumoniae Infection

Published in the journal Pediatric Drugs, this article reviews data from trials using the pneumococcal conjugate vaccine to determine the vaccine's ability to reduce and/or prevent Streptococcus pneumoniae infection. ABSTRACT ONLY. (Learn how users …

Author: Darkes M, Plosker G

Publication date: 2002

Pneumococcal Disease

This web page provides an overview of pneumococcal disease and vaccines against it. This page also provides links to World Health Organization (WHO) position papers on the disease and other related WHO resources.

Author: World Health Organization

Pneumococcal Disease

This fact sheet provides information on pneumococcal disease and prevention strategies, including vaccines against pneumococcal pneumonia. It also highlights Gavi, the Vaccine Alliance’s support for the introduction of pneumococcal vaccines in …

Author: Gavi, the Vaccine Alliance

Publication date: 2013

Pneumococcal Disease Manifestation in Children Before and After Vaccination: What's New?

This article, published in Vaccine, asserts that contrary to the common belief held by many pediatricians, the most important pneumococcal infections are of the respiratory tract and not invasive diseases. The authors explain that development of …

Author: Andrade AL, Toscano CM, Minamisava R, Costa PS, Andrade JG

Publication date: 2011

Pneumococcal Genome Sequencing Tracks a Vaccine Escape Variant Formed Through a Multi-Fragment Recombination Event

This article, published in Nature Genetics, describes a study using array-based sequencing of 62 isolates from a US national monitoring program to study five independent instances of vaccine escape recombination. The study observations clarify the …

Author: Golubchik T, Brueggemann AB, Street T, et al.

Publication date: 2012

Pneumococcal Polysaccharide Vaccine (PPSV): CDC Answers Your Questions

This fact sheet provides information for healthcare professionals on the pneumococcal polysaccharide vaccine, including vaccination recommendations from the US Centers for Disease Control and Prevention.

Author: Immunization Action Coaltion

Publication date: 2011

Pneumococcal Vaccination

This web page offers descriptions of pneumococcal disease and vaccines, links to resources, frequently asked questions, and other related information.

Author: US Centers for Disease Control and Prevention

Pneumococcal Vaccines: WHO Position Paper - 2012

This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's (WHO's) recommendations on pneumococcal vaccines and related issues, including disease surveillance, epidemiology, and studies to evaluate …

Author: World Health Organization

Publication date: 2012


This article, published in Medical Clinics of North America, summarizes the risk factors, pathogenesis, treatment, and prevention of the spectrum of disease caused by pneumococcus with particular emphasis on antibiotic resistance as well as …

Author: Ash SY, Sheffield JV

Publication date: 2013


This web page provides information on pneumonia, including links to general and technical information on the disease and pneumococcal vaccines as well as related World Health Organization programs and activities.

Author: World Health Organization


This fact sheet provides an overview of the causes, means of transmission, symptoms, risk factors, treatment, prevention, and economic costs of pneumonia. Also outlined is the World Health Organization's action plan to prevent and treat pneumonia, …

Author: World Health Organization

Publication date: 2012

Pneumonia and Diarrhoea: Tackling the Deadliest Diseases for the World’s Poorest Children

This report focuses on the huge potential to narrow the child survival gap between the richest and the poorest by focusing on pneumonia and diarrhea—the two primary killers of children under the age of five. It includes a review of the current …

Author: United Nations Children's Fund

Publication date: 2012

Pneumonia Etiology Research for Child Health

The Pneumonia Etiology Research for Child Health (PERCH) study will characterize the etiologic distribution of pathogens that are causing severe pneumonia among children under five years of age who have been hospitalized for their illness in seven …

Author: Feikin DR, Deloria-Knoll M, Murdoch DR, eds.

Publication date: 2012

The Pneumonia Etiology Research for Child Health Project: A 21st Century Childhood Pneumonia Etiology Study

This article, published in Clinical Infectious Diseases, details the Pneumonia Etiology Research for Child Health (PERCH) project, which is a seven-country, standardized, comprehensive evaluation of the etiologic agents causing severe pneumonia in …

Author: Levine OS, O'Brien KL, Deloria-Knoll M, et al.

Publication date: 2012

Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children

Published in the journal Pediatrics, this study aims to determine the population impact of pneumococcal conjugate vaccine (PCV) on pneumococcal-related diseases, including pneumonia and otitis media by measuring annual rates of medical visits for …

Author: Poehling K, Lafleur BJ, Szilagyi PG, et al.

Publication date: 2004

Post-licensure Evaluation of the Effectiveness of Seven-valent Pneumococcal Conjugate Vaccine

Published in the Pediatric Infectious Disease Journal, this study evaluates the impact of the introduction and routine use of seven valent pneumococcal conjugate vaccine on the epidemiology of invasive pneumococcal disease within the Northern …

Author: Black S, Shinefield HR, Hansen J, et al.

Publication date: 2001

Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants

This article, published in Archives of Pediatrics and Adolescent Medicine, estimates the potential effect of the acceleration of administration of the first dose of pneumococcal conjugate vaccine from two months to six weeks of age. The study …

Author: Stancil JM, Peters TR, Givner LB, Poehling KA

Publication date: 2009

Page 7 of 11